GAURAV 

 

AGGARWAL 

EXECUTIVE OFFICER

HYPERION THERAPEUTICS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  AUSPEX PHARMACEUTICALS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  UNICYCIVE THERAPEUTICS, INC.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.   |  BONUM THERAPEUTICS, INC.

ALBERT 

 

CHA 

EXECUTIVE OFFICER

NEOMEND INC   |  VICEPT THERAPEUTICS, INC.   |  TRIA BEAUTY, INC.   |  HEALTH360, INC.   |  YAUPON THERAPEUTICS INC   |  MEDLEY HEALTH, INC.   |  AIRXPANDERS INC   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  CEPTARIS THERAPEUTICS, INC   |  ACLARIS THERAPEUTICS, INC.   |  CARBYLAN BIOSURGERY, INC   |  PRONAI THERAPEUTICS INC   |  MINERVA SURGICAL INC   |  CARBYLAN THERAPEUTICS, INC.   |  ASCENDIS PHARMA A/S   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  MENLO THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.

MICHAEL 

 

CHANG 

EXECUTIVE OFFICER

GREYSTRIPE INC   |  AG FUNDS CITYPLACE REIT CORP.   |  ANSUN BIOPHARMA, INC.   |  VIVO PANDA FUND, L.P.   |  YESVIDEO INC   |  AGR IX 131 DEARBORN REIT CORP.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  INDEVR, INC.   |  MBIO DIAGNOSTICS, INC.   |  FRONTIER NUTRITION INC.   |  HERA HOLDCO, INC.   |  HERA PHYSICIAN HOLDCO, LLC   |  HERA TOPCO, INC.   |  VIVO INNOVATION FUND II, L.P.   |  NUTEX HEALTH, INC.   |  NJ NECTAR MANAGEMENT LLC   |  AEMS CORP.   |  USA BALDWIN COUNTY ASC, LLC   |  VIVO CAPITAL FUND X, L.P.   |  SWNB BANCORP INC

KEVIN 

 

DAI 

EXECUTIVE OFFICER

VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.

SHAN 

 

FU 

EXECUTIVE OFFICER

VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  VIVO ASIA OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.

FRANK 

 

KUNG 

EXECUTIVE OFFICER

SAGENT HOLDING CO.   |  REVANCE THERAPEUTICS, INC.   |  NEXTWAVE PHARMACEUTICALS INC   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  AMYRIS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  VIVO INNOVATION FUND II, L.P.   |  VIVO ASIA OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.

HONGBO 

 

LU 

EXECUTIVE OFFICER

CROWN BIOSCIENCE, INC   |  AVEDRO INC   |  TP THERAPEUTICS, INC.   |  PERFUSE THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  RGENTA THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  ZENAS BIOPHARMA (CAYMAN) LTD   |  BLOSSOMHILL THERAPEUTICS, INC.   |  ZENAS BIOPHARMA, INC.

N/A 

 

VIVO OPPORTUNITY, LLC 

PROMOTER

VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.